Premium
Does Off‐Pump Revascularization Reduce Coronary Endothelial Dysfunction?
Author(s) -
Lazar Harold L.,
Bao Yusheng,
Rivers Samuel
Publication year - 2004
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/j.0886-0440.2004.00315.x
Subject(s) - medicine , cardiopulmonary bypass , endothelial dysfunction , cardiology , revascularization , artery , anesthesia , myocardial infarction
Background: Off‐pump coronary revascularization (OPCAB) has been shown to reduce markers of acute inflammation but its effect on coronary endothelial function is unknown. This experimental study sought to determine whether OPCAB reduces endothelial dysfunction, compared to standard cardiopulmonary bypass (CPB) with and without the anticomplement agent soluble complement receptor‐1 (sCR 1 ). Methods: In 10 pigs, OPCAB was simulated by snaring the left anterior descending (LAD) artery for 15 minutes followed by 3 hours of reperfusion. On‐pump revascularization was simulated in 20 pigs by 15 minutes of LAD occlusion on CPB with cold blood cardioplegic arrest followed by 3 hours of reperfusion. Ten of these animals received sCR 1 (10 mg/kg) prior to CPB. Inflammatory response was monitored by percent (%) lung water increase, wall motion scores (WMS) with transthoracic echocardiography where 4 = normal to −1 = dyskinesia, and endothelial function in the distal LAD with bradykinin‐induced coronary artery relaxation using organ chamber methodology. Results: OPCAB had no effect on lung edema (% increase = 1.7 ± 1.4 OPCAB vs. 3.4 ± 0.5 CPB vs. 2.3 ± 0.9 CPB + sCR 1 ) and failed to prevent wall motion changes (WMS = 2.65 ± 0.08 OPCAB vs. 2.70 ± 0.04 CPB vs. 3.10 ± 0.07* CPB + sCR 1 , *p < 0.01) and coronary endothelial dysfunction (% relaxation = 41 ± 9 OPCAB vs. 40 ± 9 CPB vs. 78 ± 8** CPB + sCR 1 , **p < 0.001), which was best preserved with sCR 1 . Conclusions: This study suggests that agents which directly inhibit complement activation such as sCR 1 are more important in preventing endothelial dysfunction during coronary revascularization than merely avoiding CPB.